Symbols

Symbols

BCSF

BCSF

Bain Capital Specialty Finance: Keefe, Bruyette & Woods Maintains Market Perform Rating

Wednesday Nov 12, 2025

Bain Capital Specialty Finance: Wells Fargo Maintains Overweight, PT Down to $15

Tuesday Nov 11, 2025

Bain Capital Specialty Finance Q3 2025 Earnings Call Transcript

Monday Nov 10, 2025

Bain Capital Specialty Finance Q3 results exceed regular dividend, declares $0.42/share for Q4.

Bain Capital Specialty Q3 Earnings: $18.7mln Profit, Revenue $67.2mln

Friday Nov 07, 2025

Bain Capital Specialty Finance Q3 2025 Earnings Preview: Consensus EPS $0.45, Revenue $69.53M

Tuesday Oct 28, 2025

Bain Capital Specialty Finance Announces Q3 2025 Earnings Release and Conference Call

Bain Capital Specialty Finance Schedules Q3 Earnings Release for Nov 10.

Monday Oct 13, 2025

Bain Capital Specialty Finance: Navigating BDC Headwinds

Thursday Oct 09, 2025

Bain Capital Specialty Finance: Hidden Gem with 0.78x P/NAV and Double-Digit Yield; Rating Downgrade

Friday Aug 08, 2025

Navigating Risks in Bain Capital Specialty Finance for Safeguarded Investments

Thursday Aug 07, 2025

Bain Capital Specialty Finance, Inc. shares fall 1.25% intraday as Optum leads efforts to scale and innovate behavioral health services.

Wednesday Aug 06, 2025

Bain Capital Specialty Finance Reports Q2 2025 Results, Declares $0.42 Dividend Per Share

Bain Capital Specialty Finance shares rise 2.64% intraday after reporting solid Q2 results and declaring dividends.

Bain Capital Posts $530M in Q2 Originations, Maintains 10.2% Annualized Dividend Rate

Sickle Cell Disease Treatment Evolution: Pyruvate Kinase Activators Emerge as Promising Alternative to Gene Therapy

Bain Capital Specialty Finance Q2 2025 Earnings Call: Key Highlights and Insights

Tuesday Aug 05, 2025

Bain Capital Specialty Finance Q2 net investment income up 112% YoY, declares $0.42 per share dividend.

Bain Capital Specialty Finance Announces Q2 2025 Financial Results and Declares $0.42 Dividend per Share

Monday Aug 04, 2025

Bain Capital Specialty Finance Q2 Earnings Preview: EPS Down 13.7%, Revenue Down 6.1% Y/Y.